Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Response Study for Duration of Analgesia Using Bupivacaine and Ropivacaine for Infragluteal Parabiceps Sciatic Block

NCT01272921 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT01272921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01272921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Response Study for Duration of Analgesia Using Bupivacaine and Ropivacaine for Infragluteal Parabiceps Sciatic Block
Lead sponsor
Northwestern University
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2010
Completion date
Not reported
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the duration of motor block may vary between 12-36 hrs